BioMarin Pharmaceutical
BMRN
#1907
Rank
ยฃ7.70 B
Marketcap
ยฃ40.08
Share price
-0.78%
Change (1 day)
-22.69%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: ยฃ7.70 Billion

As of December 2025 BioMarin Pharmaceutical has a market cap of ยฃ7.70 Billion. This makes BioMarin Pharmaceutical the world's 1907th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ7.70 B-24.19%
2024ยฃ10.15 B-28.74%
2023ยฃ14.25 B-10.33%
2022ยฃ15.89 B32.3%
2021ยฃ12.01 B2.9%
2020ยฃ11.67 B0.71%
2019ยฃ11.59 B-3.03%
2018ยฃ11.95 B3.2%
2017ยฃ11.58 B0.35%
2016ยฃ11.54 B1.12%
2015ยฃ11.41 B31.9%
2014ยฃ8.65 B41.49%
2013ยฃ6.11 B59.77%
2012ยฃ3.82 B51.59%
2011ยฃ2.52 B30.9%
2010ยฃ1.93 B64.46%
2009ยฃ1.17 B-3.2%
2008ยฃ1.21 B-29.94%
2007ยฃ1.73 B125.47%
2006ยฃ0.76 B65.24%
2005ยฃ0.46 B116.35%
2004ยฃ0.21 B-22.86%
2003ยฃ0.27 B17.69%
2002ยฃ0.23 B-51.32%
2001ยฃ0.48 B102.68%
2000ยฃ0.23 B-5.38%
1999ยฃ0.25 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of BioMarin Pharmaceutical was reported to be:

ยฃ7.70 Billion
by Nasdaq info icon info icon
ยฃ7.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
ยฃ2.63 B-65.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ0.12 B-98.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
ยฃ0.66 B-91.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ90.75 B 1,078.48%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
ยฃ2.29 B-70.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ2.17 B-71.81%๐Ÿ‡บ๐Ÿ‡ธ USA